Leo Kim, MD
Enriched profileAssociate Professor of Ophthalmology at Harvard Medical School; Incumbent of the Monte J. Wallace Ophthalmology Chair in Retina at Massachusetts Eye and Ear · Massachusetts Eye and Ear Infirmary
Leo Kim is Associate Professor of Ophthalmology at Harvard Medical School; Incumbent of the Monte J. Wallace Ophthalmology Chair in Retina at Massachusetts Eye and Ear at Massachusetts Eye and Ear Infirmary. OpenAlex indexes 211 publications with 5,358 citations (h-index 37); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 17 Oct 2026
Overview
Updated 17 Oct 2026
Leo Kim, M.D., PH.D., is Associate Professor of Ophthalmology at Harvard Medical School at Massachusetts Eye and Ear Infirmary. The public record shows 211 publications with 5,358 citations (h-index 37), centered on Retinal Diseases and Treatments, Retinal Imaging and Analysis, Retinal and Macular Surgery. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 12 companies, 2 NIH-funded awards (2016–2022).
- Most recent indexed publication: 2026 · Research square
- Top research focus: Retinal Diseases and Treatments
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 12 companies
Generated from the cited public record · current as of 17 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 14 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 85.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 17 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy
Sponsor: Massachusetts Eye and Ear Infirmary
- Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
Sponsor: Massachusetts Eye and Ear Infirmary
Industry payments
Updated 17 Oct 2026
12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year20253 payments
- Stryker CorporationProgram year20252 payments
- Ocular Therapeutix, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
65.7%Corticosteroid41.4%Prednisolone Acetate100%Part D≥16 patientsCarbonic Anhydrase Inhibitor24.3%Dorzolamide-Timolol100%Part D<11 patientsMusculoskeletal
34.3%Cyclooxygenase Inhibitor34.3%Ketorolac Tromethamine100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 17 Oct 2026
2 NIH research awards on record, funded 2016–2022 per NIH RePORTER. The latest:
- Role of Runx1 in Pathologic Ocular Angiogenesis
Schepens Eye Research Institute
FY2022$502,164R01EY027739 - Role of Runx1 in Pathologic Ocular Angiogenesis
Schepens Eye Research Institute
FY2021$528,075R01EY027739 - Role of Runx1 in Pathologic Ocular Angiogenesis
Schepens Eye Research Institute
FY2020$544,408R01EY027739
Publications
Updated 17 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Influence of Anti-VEGF Injections on Longitudinal Changes in Vascular Metrics Measured by OCTA in Age Related Macular Degeneration: A Retrospective Real-World Study.
Clinical ophthalmology (Auckland, N.Z.)
Article2026 - An mRNA-encoded dominant-negative inhibitor of transcription factor RUNX1 suppresses vitreoretinal disease in experimental models.
Science translational medicine
Article2024 - Associations of quantitative contrast sensitivity with wide-field swept-source optical coherence tomography angiography in retinal vein occlusion.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Article2024
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03A Dramatic Increase of C1q Protein in the CNS during Normal AgingArticle423 citations2013
- 04A Brief History of Anti-VEGF for the Treatment of Ocular AngiogenesisArticle220 citations2012
- 05Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous manArticle192 citations2023
Network
Updated 17 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 17 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
- PhD
Yale School of Medicine Medical Scientist Training Program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eye.hms.harvard.edu ↗
Editorial & leadership roles
journal and society appointments- Fellow (FAAO)
American Academy of Ophthalmology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eye.hms.harvard.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eye.hms.harvard.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eye.hms.harvard.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eye.hms.harvard.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →eye.hms.harvard.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Dean Eliott, MD
Massachusetts Eye and Ear Infirmary
Daniel Liebman, MD
Massachusetts Eye and Ear Infirmary
Neil Bhattacharyya, MD, FACS
Massachusetts Eye and Ear Infirmary
Demetrios Vavvas, MD, PhD
Massachusetts Eye and Ear Infirmary
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Richard Spaide, MD
Vitreous Retina Macula Consultants of New York